Outcomes of Window Therapy with Carboplatin and Ifosfamide for Pediatric Osteosarcoma: A Case Series

• Main Authors: Hisaki Aiba (Author), Michi Kamei (Author), Yasuhiko Ito (Author), Risa Takeda (Author), Satoshi Yamada (Author), Hideki Okamoto (Author), Katsuhiro Hayashi (Author), Shinji Miwa (Author), Yohei Kawaguchi (Author), Shiro Saito (Author), Takao Sakai (Author), Hideki Murakami (Author), Hiroaki Kimura (Author)
• Format: Book
• Published: MDPI AG, 2023-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

For the treatment of osteosarcoma, cisplatin (CDDP) can be substituted by carboplatin (CBDCA) to reduce toxicity. We report a single institution experience of CBDCA-based regimen. Two to three cycles of CBDCA + ifosfamide (IFO) therapy (window therapy) were administered as neoadjuvant therapy for os...